ClinicalTrials.Veeva

Menu

The Effect of Programmed Intermittent Epidural Bolus Versus Continuous Epidural Infusion on Postoperative Analgesia in Pediatric Patients

Yonsei University logo

Yonsei University

Status

Unknown

Conditions

Correctional Osteotomy

Treatments

Device: Programmed intermittent epidural bolus
Device: Continuous epidural infusion

Study type

Interventional

Funder types

Other

Identifiers

NCT04010032
4-2019-0418

Details and patient eligibility

About

The aim of this study was to compare the efficacy of a programmed intermittent bolus injection method compared to conventional continuous infusion in the management of epidural analgesia in pediatric patients correctional osteotomy. As a prospective double blinded randomized controlled trial, the investigators compare the quality of pain control after surgery.

Enrollment

60 estimated patients

Sex

All

Ages

4 to 13 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

    1. Pediatric patients with between 4 and 13 years
    1. Patients scheduled for correctional osteotomy of the lower extremity
    1. Pediatric patients whose weight of 40kg of less

Exclusion criteria

    1. Contraindications to epidural analgesia (local infection, blood clotting disorder, anatomical abnormality, sepsis, etc.)
    1. Patients with symptoms/signs of elevated intracranial pressure with or without a history of elevated intracranial pressure
    1. If all of the parents of the subject are foreigners or illiterate (if the parents of the subject can not read the agreement)

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

60 participants in 2 patient groups

PIEB (Programmed intermittent epidural bolus)
Experimental group
Description:
bolus administration of 0.15 ml of ropivacaine 0.15 ml / kg into epidural space every hour(intermittent bolus injection)
Treatment:
Device: Programmed intermittent epidural bolus
CEI (Continuous epidural infusion)
Active Comparator group
Description:
Continuous infusion of 0.15% ropivacaine 0.15 ml / kg / h into the epidural space using PCA device
Treatment:
Device: Continuous epidural infusion

Trial contacts and locations

1

Loading...

Central trial contact

Yong Seon Choi, MD., PhD.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems